Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Screentec Signals Discovery Ambitions With Name Change

May 8, 2002

By Cormac Sheridan

Screentec Signals Discovery Ambitions With Name Change

May 8, 2002

By Cormac Sheridan

Personal Chemistry Purchases ESyTech To Extend Platform

May 8, 2002

By Cormac Sheridan

Swiss Firm Axovan Raises CHF30M In Second Round

May 1, 2002

By Cormac Sheridan

Newron Raises EUR18.5 Million In Second Round For CNS Drugs

May 1, 2002

By Cormac Sheridan

Glaucus Proteomics Logs On To Dutch Supercomputing Facility

May 1, 2002

By Cormac Sheridan

NeuroSearch Stops Development Of NS3728 For Sickle-Cell Anemia

May 1, 2002

By Cormac Sheridan

Newron Raises EUR18.5 Million In Second Round For CNS Drugs

May 1, 2002

By Cormac Sheridan

Swiss Firm Axovan Raises CHF30M In Second Round

May 1, 2002

By Cormac Sheridan

Glaucus Proteomics Logs On To Dutch Supercomputing Facility

May 1, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...